Mutation in Brief

You have free access to this content

Identification of 34 novel and 56 known FOXL2 mutations in patients with blepharophimosis syndrome†

  1. Diane Beysen1,
  2. Sarah De Jaegere1,
  3. David Amor2,
  4. Philippe Bouchard3,
  5. Sophie Christin-Maitre3,
  6. Marc Fellous4,
  7. Philippe Touraine5,
  8. Arthur W. Grix6,
  9. Raoul Hennekam7,
  10. Françoise Meire8,9,
  11. Nina Oyen10,
  12. Louise C. Wilson11,
  13. Dalit Barel12,
  14. Jill Clayton-Smith13,
  15. Thomy de Ravel14,
  16. Christian Decock8,
  17. Patricia Delbeke8,
  18. Regina Ensenauer15,
  19. Friedrich Ebinger16,
  20. Gabriele Gillessen-Kaesbach17,
  21. Yvonne Hendriks18,
  22. Virginia Kimonis19,
  23. Rachel Laframboise20,
  24. Paul Laissue4,
  25. Kathleen Leppig21,
  26. Bart P. Leroy1,8,
  27. David T. Miller22,
  28. David Mowat23,
  29. Luitgard Neumann24,
  30. Astrid Plomp25,
  31. Nicole Van Regemorter26,
  32. Dagmar Wieczorek17,
  33. Reiner A. Veitia4,
  34. Anne De Paepe1,
  35. Elfride De Baere1,*

Article first published online: 18 JUL 2008

DOI: 10.1002/humu.20819

Issue

Human Mutation

Human Mutation

Special Issue: Special Issue: Assessing Mutation Pathogenicity in Cancer Susceptibility Genes

Volume 29, Issue 11, pages E205–E219, November 2008

Additional Information

How to Cite

Beysen, D., De Jaegere, S., Amor, D., Bouchard, P., Christin-Maitre, S., Fellous, M., Touraine, P., Grix, A. W., Hennekam, R., Meire, F., Oyen, N., Wilson, L. C., Barel, D., Clayton-Smith, J., de Ravel, T., Decock, C., Delbeke, P., Ensenauer, R., Ebinger, F., Gillessen-Kaesbach, G., Hendriks, Y., Kimonis, V., Laframboise, R., Laissue, P., Leppig, K., Leroy, B. P., Miller, D. T., Mowat, D., Neumann, L., Plomp, A., Van Regemorter, N., Wieczorek, D., Veitia, R. A., De Paepe, A. and De Baere, E. (2008), Identification of 34 novel and 56 known FOXL2 mutations in patients with blepharophimosis syndrome. Hum. Mutat., 29: E205–E219. doi: 10.1002/humu.20819

Author Information

  1. 1

    Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium

  2. 2

    Genetic Health Services Victoria, Royal Children's Hospital, Parkville, Australia

  3. 3

    Service d'Endocrinologie, Hôpital Saint-Antoine, Paris, France

  4. 4

    INSERM U709 Génomique et Epigénétique des Pathologies Placentaires and Universités Paris V & VII, Paris, France

  5. 5

    Department of Endocrinology and Reproductive Medicine, Pitie-Salpetrière Hospital, Paris, France

  6. 6

    The Permanente Medical Group, Department of Medical Genetics, Sacramento, California, USA

  7. 7

    Department of Pediatrics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  8. 8

    Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium

  9. 9

    Ophthalmology Department, HUDERF-ULB, Brussels, Belgium

  10. 10

    Center of Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway

  11. 11

    Clinical and Molecular Genetics Unit, Institute of Child Health and Great Ormond Street Hospital, London, UK

  12. 12

    The Genetic Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

  13. 13

    Academic Department of Medical Genetics, St. Mary's Hospital, Manchester, United Kingdom

  14. 14

    Center for Human Genetics, Catholic University of Leuven, Belgium

  15. 15

    Departments of Laboratory Medicine & Pathology and Medical Genetics, Mayo Clinic College of Medicine, Rochester, USA

  16. 16

    Department of Pediatric Neurology, University Children's Hospital, Heidelberg, Germany

  17. 17

    Universitätsklinikum Essen, Institut für Humangenetik, Essen, Germany

  18. 18

    Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands

  19. 19

    Department of Pediatrics, University of California, Irvine, Orange, California, USA

  20. 20

    Clinical Genetics Division, Department of Paediatrics and Medicine, CHUL, CHUQ, Faculty of Medicine, Laval University, Quebec, Canada

  21. 21

    Genetic Services, Group Health Cooperative (K.A.L.), Seattle, USA

  22. 22

    Division of Genetics, Children's Hospital, Boston, USA

  23. 23

    Sydney Children's Hospital, Dept of Clinical Genetics, Randwick, Australia

  24. 24

    Humangenetik, Charite Campus Virchow, Berlin, Germany

  25. 25

    Netherlands Institute for Neuroscience, an institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands

  26. 26

    Medical Genetics Department, Hôpital Erasme-ULB, Brussels, Belgium

*Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium

  1. †

    Communicated by David L. Rimoin

Publication History

  1. Issue published online: 24 OCT 2008
  2. Article first published online: 18 JUL 2008
  3. Manuscript Accepted: 28 MAR 2008
  4. Manuscript Received: 16 OCT 2007

Funded by

  • grant BOF2002/ DRMAN/047 from the Bijzonder Onderzoeksfonds from Ghent University (to D.B.)
  • grant 1.5.244.05 from the Research Foundation - Flanders (FWO-Vlaanderen) (to E.D.B.)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (1071K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sandrine Caburet, Adrien Georges, David L’Hôte, Anne-Laure Todeschini, Bérénice A. Benayoun, Reiner A. Veitia, The transcription factor FOXL2: At the crossroads of ovarian physiology and pathology, Molecular and Cellular Endocrinology, 2012, 356, 1-2, 55

    CrossRef

  2. 2
    Christian E. Decock, Ilse Claerhout, Bart P. Leroy, Philippe Kesteleyn, Akash D. Shah, Elfride De Baere, Correction of the Lower Eyelid Malpositioning in the Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome, Ophthalmic Plastic & Reconstructive Surgery, 2011, 27, 5, 368

    CrossRef

  3. 3
    Jia-Yan Fan, Ye-Fei Wang, Bing Han, Yong-Rong Ji, Huai-Dong Song, Xian-Qun Fan, FOXL2 mutations in Chinese families with Blepharophimosis syndrome (BPES), Translational Research, 2011, 157, 1, 48

    CrossRef

  4. 4
    Wei-De Lin, I-Ching Chou, Ni-Chung Lee, Chung-Hsing Wang, Wuh-Liang Hwu, Shuan-Pei Lin, Mei-Chyn Chao, Yushin Tsai, Fuu-Jen Tsai, FOXL2 mutations in Taiwanese patients with blepharophimosis, ptosis, epicanthus inversus syndrome, Clinical Chemistry and Laboratory Medicine, 2010, 48, 4, 485

    CrossRef

  5. 5
    L Kraoua, M Chaabouni, M Trabelsi, I Chelly, F Maazoul, N Ben Abdallah, S Boukthir, S Barsaoui, H Chaabouni, R M’rad, FOXL2 mutations in Tunisian patients with blepharophimosis–ptosis–epicanthus inversus syndrome, Clinical Genetics, 2010, 77, 6
    Direct Link:
  6. 6
    Ibtissem Chouchene, Kaouthar Derouiche, Afif Chaabouni, Lamia Cherif, Ahlem Amouri, Leila Largueche, Sonia Abdelhak, Leila El Matri, Identification of a Novel Mutation inFOXL2Gene That Leads to Blepharophimosis Ptosis Epicanthus Inversus and Telecanthus Syndrome in a Tunisian Consanguineous Family, Genetic Testing and Molecular Biomarkers, 2010, 14, 1, 145

    CrossRef

  7. You have free access to this content7
    Diane Beysen, Anne De Paepe, Elfride De Baere, FOXL2 mutations and genomic rearrangements in BPES, Human Mutation, 2009, 30, 2
    Direct Link:
  8. 8
    A.L. Chand, C.A. Harrison, A.N. Shelling, Inhibin and premature ovarian failure, Human Reproduction Update, 2009, 16, 1, 39

    CrossRef

  9. 9
    A. Dipietromaria, B. A. Benayoun, A.-L. Todeschini, I. Rivals, C. Bazin, R. A. Veitia, Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems, Human Molecular Genetics, 2009, 18, 17, 3324

    CrossRef

Get PDF (1071K)